Zentalis Pharmaceuticals, Inc.
ZNTL
$2.76
$0.093.37%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
4/1/2026
-
Globe Newswire
3/30/2026
-
MarketBeat
3/30/2026
-
Ticker Report
3/28/2026
-
MarketBeat
3/28/2026
-
TipRanks Financial Blog
3/28/2026
-
TipRanks Financial Blog
3/28/2026
-
Simply Wall St
3/28/2026
-
Simply Wall St
3/27/2026
-
MarketBeat
3/27/2026
-
TipRanks Financial Blog
3/26/2026
-
MarketBeat
3/26/2026
-
SeekingAlpha.com: All News
3/26/2026
-
Globe Newswire
3/20/2026
-
Ticker Report
3/19/2026
-
MarketBeat
3/18/2026
-
MarketBeat
3/17/2026
-
Globe Newswire
3/17/2026
-
MarketBeat
3/15/2026
-
MarketBeat
3/11/2026
-
Tickeron - Stocks
3/10/2026
-
Ticker Report
2/27/2026
-
Ticker Report
2/22/2026
-
MarketBeat
2/18/2026
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 26, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
212 433 3791
Address
10275 Science Center Dr.
San Diego, CA 92121
San Diego, CA 92121
Country
Year Founded
Business Description
Sector
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United...
more